Reduced bioenergetics and toll-like receptor 1 function in human polymorphonuclear leukocytes in aging
Feng Qian1, Xiuyang Guo, Xiaomei Wang
1Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Aging
|March 6, 2014
Summary
Aging impairs immune cells called polymorphonuclear leukocytes (PMN) by reducing Toll-like receptor 1 (TLR1) expression and energy production. This age-related decline in PMN function increases infection susceptibility in older adults.
Area of Science:
- Immunology
- Gerontology
- Cellular Biology
Background:
- Aging leads to immunosenescence, a decline in immune function, increasing susceptibility to infections.
- Polymorphonuclear leukocytes (PMN) are crucial for innate immunity, and their function may be compromised with age.
Purpose of the Study:
- To investigate the impact of aging on Toll-like receptor 1 (TLR1) expression and function in PMN.
- To examine age-related changes in PMN bioenergetics and their correlation with immune responses.
Main Methods:
- Compared TLR1 expression and response in PMN from young (21-30 years) and older (>65 years) adults.
- Assessed PMN activation markers (integrins, IL-8, p38 MAP kinase, CD62L) and apoptosis rescue upon TLR1 stimulation.
- Measured glucose uptake and bioenergetic efficiency in PMN from different age groups.
Main Results:
- Older adults exhibited reduced TLR1 expression and impaired TLR1-mediated PMN activation, including lower integrin activation, IL-8 production, and p38 MAP kinase phosphorylation.
- PMN from older adults showed reduced CD62L shedding and less efficient rescue from apoptosis when stimulated via TLR1.
- A significant age-dependent deficiency in PMN bioenergetics, particularly reduced glucose uptake after TLR1 stimulation, was observed in older individuals.
Conclusions:
- Aging is associated with decreased TLR1 expression and function in PMN, alongside impaired bioenergetics.
- These age-related deficits in PMN function likely contribute to increased infection risk in older adults.
- Findings suggest potential therapeutic targets to enhance PMN function in the elderly.
Related Concept Videos
The Effect of Aging on Tissues
3.6K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
Aging
1.1K
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
400
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
Mitochondria
13.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.4K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
382
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
382


